ODS Expects Positive Impact On Industry From Promoting Supplement Science
This article was originally published in The Tan Sheet
Executive Summary
The National Institutes of Health's Office of Dietary Supplements does not operate to promote supplement products, but shares a common interest with industry that can help spur businesses' growth - disseminating information and improving research, says ODS Director Paul Coates
You may also be interested in...
FDA Identifies "Fatal Flaws" That Block Approval Of Health Claims
FDA likely will refuse new health claims applications if petitioners fail to provide relevant studies in healthy humans that evaluate the relationship between the substance and the disease, an agency official says
FDA Health Claims Draft Guidance Should Value Totality Of Evidence – CRN
FDA's apparent contention that results from randomized controlled trials invalidate conflicting information from observational studies on the effects of nutrients reflects "an intrinsic bias" within the agency or "a lack of fundamental understanding of research methods," according to the Council for Responsible Nutrition
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC